There are still quite a few unanswered questions regarding the novel food application process under the FSA. Fortunately the requirement of having toxicological data
Although still illegal in the US and Canada, psychedelic substances such as fungus-derived psilocybin are becoming increasingly acceptable, research suggests
Commercial interest in mushrooms as active ingredients is on the rise – despite legal issues that severely curtail commercial opportunities
Maria Alejandra Estanga, our market analysts, presented the current status of the topicals market across the most important CBD markets during the Virtual Cannacosmo Health + Beauty Expo on 29st September.
US-based CBD producer Folium Biosciences is looking to tap Asian markets by creating a dedicated stalk extraction line which it believes will meet the strict regulatory requirements of Japan and South Korea
The Association for the Cannabinoid Industry (ACI) will move forward with its consortium approach to obtaining toxicology and safety data for CBD with at least 15 companies having signed up and an undisclosed number still in discussion
2020 seems an unlikely year for the emergence of any new industry, yet this is exactly what has happened in Hong Kong, where there are now locally produced CBD food and drink products
Britain’s newfound enthusiasm for CBD products has joined with the passion for alcohol, with some companies are aiming to capitalise on the trend for “drinking less but drinking better” by launching CBD spirits, especially gin
Studies looking at the potential for CBD to treat or alleviate COVID-19 symptoms continue to progress – with one study hinting at promising results combining CBD with other terpene products
Nanotechnology – referring to any kind of technology dealing in very small scales such as atomic, molecular or supramolecular – could improve some of the disadvantages of cannabinoids, such as solubility
Scientists are increasingly starting to study how differing methods of consumption can affect CBD bioavailability – the ability to enter your bloodstream and induce effects
Maria Alejandra Estanga, one of CBD-Intel’s market analysts, presented the latest CBD market trends & country comparison at the CBD live during VOXPO – Virtual Online Vape & CBD Expo on 31st July.
Current indications are that the EC is leaning heavily towards the idea that CBD does indeed count as a narcotic under the 1961 Un Convention.
A new line of sparkling CBD drinks is to be launched in the Colorado market in what may be an indication of how high-profile companies approach the CBD market during its continued period of uncertainty
A CBD oil made by Brazilian drugs company Prati-Donaduzzi could become the biggest-selling cannabinoid product on the Brazilian market
Also: Drug mart deal for CBD on prescription; A little hemp in your tea, sir?; Celebrity cook denies endorsing CBD; Convenience store chain to sell CBD snacks; UK firm launches CBG hand cleanser; CBD products on Circle K shelves; Hawaii distribution deal
Two companies have independently come up with the same general solution to major CBD problems. Micelle encapsulation replicates the body’s normal internal process of absorbing fats. The process used by the companies encapsulates CBD in micelles
Other stories here: Frustrated wine-grower turns to hemp research; Patent given for CBD/CBG ‘micropearl’; GW reclaims UK rights to Sativex; Kentucky crop to be destroyed; Fight goes on over rights to cream formula
Testing in the field could counter a major stated reason for enacting bans on smokable hemp in the US, but a perfect technical solution has not yet been found
Toothpaste giant Colgate is entering the CBD market, researchers have created a laser scanner that can tell the difference between legal hemp and potentially illegal cannabis, and wrestling legend Kevin Nash has become the latest celebrity to endorse CBD, plus more
TobaccoIntelligence, a new service from the team that produces CBD-Intel, is now available, covering the global tobacco and nicotine alternatives sector
Tom Hanks refutes false claims over endorsement of CBD products, research suggests cannabinoids benefit gene receptor diseases and CBD coffee is set to hit the market, plus more
Getting flavours right for CBD products requires custom solutions that can compensate for inconsistency in production but the objectives can broadly be placed in one of four categories
A US-based hemp research firm is working with a university in Florida to create an FDA-approved capsule that could replicate the painkilling abilities of ibuprofen
Two new studies have shown hopeful signs that CBD could be combined with existing drugs to improve treatment – in one case, of cancer, and in the other of the potentially deadly E. coli
CBD-Intel brings you news that a rugby league team will be the first senior outfit in its sport to promote a CBD brand on its kit, a qualification for hemp production is offered in Kentucky and a US business gains USDA organic certification, plus more
RnB star Tionne “T-Boz” Watkins has launched her own range of CBD products. The former TLC star’s TLCBD items include beauty serums, face creams, lip balms, pain relief balms, oral tinctures, and gummies, as well as tinctures for pets. New equipment boosts Upper Street extraction capacity A Californian company has announced the acquisition of […]
CBD-Intel brings you news on the availability of bank loans, new processing ventures and other moves in the CBD business world
CBD-Intel’s regular round-up of business news in brief revisits the strange case of the Fed Ex tip-off that got New York police confused
CBD-Intel’s regular podcasts provide expert insight into global regulation, market trends and the latest developments. Join us to find out more about this fast-moving industry with the CBD-Intel team. Thanks for listening!
A Colorado company is to pilot the use of CBD vending machines in convenience stores. Other news items come from the UK, South Africa, and states across the US from California to Vermont
A CBD company is trying to convince other vendors to give up selling CBD oils, believing the variable bioavailability of oils will hold the industry back
A bumper crop of business briefs includes news of a “unique 4D, shape-changing cannabinoid and active ingredient delivery system”
A legal battle between a Canadian cannabis company and a US hemp company leads this round-up of business news in brief. Also covered are stories from Australia, Germany, and a number of US states
Researchers in Canada have for the first time revealed how CBD can block unwanted THC-related side-effects of cannabis. Also: Can CBD relieve anxiety disorders? and the therapeutic potential of ‘Turbo’ oil tested
CBD with legally-permitted levels of psychotropic elements can be derived from varieties containing higher levels of THC using better extraction techniques, according to an industry expert
Funding success for new developments in hemp research, as well as innovations such as monitoring the path of pollen using drones
CBD-Intel brings you business and related news in brief from the US, China, Israel and UK
A San Francisco-based CBD firm is donating all September profits from its bestselling line to Leonardo DiCaprio’s Earth Alliance Amazon Forest Fund. This and other business news in brief
Experts have criticised plans by the Irish government to turn the country’s dwindling peat bogs into hemp farms that could produce the raw material for CBD products
Information from the US, the UK, Canada and Africa, including how more than half of the hemp crops planted in Hawaii have had to be destroyed due to THC content being over the permitted levels
Items from China, Thailand, Colombia, Israel, the US, Canada, UK and Ireland include news of the political leader’s son who is planning to open a hemp store, with dad’s blessing
Kylie Jenner gets happy – CBD-Intel’s weekly round-up of business snippets includes items from the US, Canada, Ireland and Australia
A new clinical trial is investigating the efficacy of CBD-infused mouthwashes and toothpaste when used to treat gum disease. The randomised controlled clinical trial is a collaboration between Australian medicinal cannabis business Impression Healthcare and US-based pharmaceutical-grade medical cannabis producer AXIM Biotechnologies.
CBD vaping stakeholders in Europe expect to see the category continue to grow – fuelled by unclear regulations over CBD as a food ingredient combined with a low barrier to entry
The latest news and developments in the CBD industry worldwide rounded up in CBD-Intel’s weekly News In Brief.
The sports world is becoming increasingly enamoured with CBD. US professional golfers have become the latest sporting personalities to endorse CBD products, including 2009 US Open winner Lucas Glover.
Will CBD continue to wind its way into the professional sporting arena in the US and Canada – and even further afield?
Interest and investment in CBD beverages continues to grow despite some criticism of cannabis drinks in general; so far, the industry has struggled to get oil-based cannabinoids into water-based beverages without issues. But all of that is changing, rapidly…
CBD manufacturers could and should look at using a fermentation process to extract cannabidiol, a new report suggests
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up, bringing updates from the US, Canada, London, Hungary, Spain, Google and Facebook
CBD as a Novel Food: the future for edibles in Europe
This new CBD-Intel report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway.
Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.
This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.
Free sample available
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
